Australia’s largest locally-owned pharmaceutical company specialising in dermatology, Ego Pharmaceuticals has begun construction of its new global headquarters that will include a manufacturing facility and a distribution centre.
The new $135 million dollar manufacturing facility is being built in Dandenong south and is set to be completed by the end of 2017.
The project will create 200 new jobs and will boost the pharmaceutical manufacturing industry in Victoria.
“This development will enable us to grow exponentially and continue to drive our manufacturing and export business, it secures the future of our business in Victoria to continue to grow and innovate as industry leaders to meet the needs of our consumers,” said Ego Pharmaceuticals Managing Director Alan Oppenheim.
“We are proud to be driving this growth from Victoria to the world. Australian manufacturing and exporting has significant benefits to the wider economy and we’re committed to continuing to innovate, invest in Australians and lead the industry with our world class practices from state of the art facilities.”
Ego Pharmaceuticals employs 295 people in Victoria and a further 155 people interstate and overseas.
“This major investment by Ego Pharmaceuticals cements Victoria’s position as a leading centre for pharmaceutical manufacturing and ensures the company’s products continue to be manufactured in Melbourne for the Australian and global market,” said Minister for Industry Lily D’Ambrosio.
All Ego products are currently manufactured in Braeside, Victoria. Demand from export markets is helping to drive the company’s growth with 34 per cent of product going overseas to 25 nations with Ego’s biggest growth coming from Asia and the Middle East.